FDA Approves Pill Version Of Novo Nordisk’s Wegovy—A First For GLP-1s
The pill is the first FDA-approved oral GLP-1 medication for weight management.
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk (Annika Kim Constantino/CNBC)
Annika Kim Constantino / CNBC: FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk … The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts say could open up treatment access to more patients.
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
As we approach the final weeks of 2025, the U.S. healthcare sector has transitioned from a defensive stalwart to a primary market leader. Evidently, while the S&P 500 has delivered a solid return of approximately 15% year to date, the U.S. healthcare index has been consistently challenging this benchmark, with specific sub-sectors like biotechnology outperforming […]
GLP-1 adherence lags among older adults: 6 notes
A growing body of research suggests that older adults are discontinuing GLP-1 medications at high rates, The New York Times reported Dec. 21. Six things to know: 1. Sixty percent of Americans over age 65 with diabetes discontinued semaglutide within one year, according to a recent study published inJAMA Cardiology. A separate study published earlier […]
AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users – Morningstar
AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users Morningstar
Applied Nutrition partners with Morrisons in GLP-1 ready meals
Applied Nutrition has entered an exclusive three-year agreement with Morrisons to introduce a “GLP-1 friendly” ready-meals range. The post Applied Nutrition partners with Morrisons in GLP-1 ready meals appeared first on Just Food.
Eli Lilly and Company (LLY) Announces Updated Meaningful Data on Breast Cancer Treatment
Eli Lilly and Company (NYSE:LLY) is one of the best forever stocks to buy according to hedge funds. On December 15, Goldman Sachs lifted its price target on Eli Lilly and Company (NYSE:LLY) to $1,145 from $951 while reiterating a Buy rating on the stock. Pixabay/Public Domain On December 12, Eli Lilly and Company provided […]
Beverage-makers craft next generation of products targeting weight loss
The rise of GLP-1 usage along with other trends converging with obesity and obesity drugs, is prompting interest in weight management formulations within the beverage market.
Chipotle’s unveils new ‘GLP-1 friendly’ menu – here’s how Ozempic is changing fast food restaurants forever
Here’s the skinny on Chipotle’s new menu.
The throughline between Ozempic and Prozac
And more health news from Morning Rounds today